FDA issued a Warning Letter to Zhejiang Huahai Pharmaceutical on 11/29/2018 as a result of this inspection.
483 Zhejiang Huahai Pharmaceutical Aug 2018

483 Zhejiang Huahai Pharmaceutical Aug 2018

Cheryl Clausen FDA, Joel Hustedt FDA$119.00 - Available Now

FDA investigators audited the Zhejiang Huahai Pharmaceutical - Linhai, China facility and issued inspectional observations (via FDA 483) on 03 Aug 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 03 Aug 2018
  • Location: Linhai, China
  • FEI: 3003885745
Add To Cart